Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

The information on this page is intended for news media in the European Union only.

February 7th, 2022

Cook Medical Reproductive Health business to be acquired by CooperCompanies

Limerick, Ireland — Cook Medical today announced it signed a letter of intent withCooperCompanies to sellthe entirety of Cook’s Reproductive Healthbusinesswithin the MedSurg division. CooperCompanies (NYSE:COO), a publicly held healthcare company, is focused on women’s health and fertility solutions, providing innovative products and services for every step in the ART journey. Under the proposed transaction, CooperCompanies will pay $875 million, comprising $675 million at closing and $200 million paid in four $50 million annual installments. The proposed transaction is subject to compliance with applicable local consultation obligations and regulatory approvals.

For more than 40 years, Cook has had a focus on Reproductive Health, successfully developing products for obstetrics and gynaecology, In Vitro Fertilisation (IVF) and Assisted Reproductive Technology (ART).  Cook’s history with Reproductive Health is full of innovations that help patients fulfill their dreams of having a family, including developing the first needle specifically for IVF treatments. 

“Our history with reproductive health has been full of innovations to help patients fulfill their dreams of having a family,” said D.J. Sirota, senior vice president of Cook Medical’s MedSurg specialty. “This agreement represents more than a simple transaction; it is a commitment to offer a more complete range of solutions to customers and patients around the world. CooperSurgical is uniquely positioned to combine Cook’s reproductive health portfolio with their resources and plans to significantly invest in this product portfolio.”

William Cook Australia, Cook Spencer, and Cook Vandergrift all currently manufacture reproductive health devices. After the closing of the transaction, Cook will continue to manufacture products for CooperSurgical during a two-year transition period and will increase manufacturing capacity to keep up with growth. No manufacturing jobs are at risk because of this partnership. Employees in manufacturing who support these products will continue to do so during the transition period and eventually will cross-train to manufacture other Cook Medical products.  

“Like we always have been, we remain committed to the communities where we have facilities and employees, including Spencer, Vandergrift and Brisbane, where these products are manufactured,” said Pete Yonkman, president of Cook Medical and Cook Group. “This agreement will allow us to invest in future growth and new technologies. The rest of the Cook organisation will continue as privately held, family-owned companies with no plans to change that status.”  

Media kit with animations and b-roll available upon request. 

About Cook Medical

Since 1963, Cook Medical have been inventing, manufacturing and delivering a unique portfolio of medical devices to healthcare systems around the world. We work closely with physicians to develop technologies that improve patients’ lives. Because we remain family owned, we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at, and for the latest news, follow us on TwitterFacebook and LinkedIn.

Media Contact:
Marsha Lovejoy
Global Manager, Public Relations, Cook Medical
812-320-6903 (mobile)